April 22, 2026

PwD Advisory Committee Meeting – April 22, 2026 

Participants: Emily Coppedge, Emily DeWit, Amy Ohmer, Kristi Quairoli, Craig Bobik, Stephanie Ogburn, Stacey Spirrison, Rachael Lee, Emma Mason, Sarah Dempsey, Katie Hester, Nicole Rioles, Claire Rainey, Alyssa Cabrera 

Slide Deck: https://t1dx-qi.t1dexchange.org/wp-content/uploads/2026/04/PwD-April-2026.pdf 
 

Welcome and Introductions 

Emily Coppedge, CPNP, CDCES, opened the meeting by welcoming attendees. Participants introduced themselves. 

Caregiver Quick Reference Guides – Updates 

The committee reviewed updates to the caregiver quick reference guides, which now include additional insulin pump and glucagon manufacturers. 

• Included Glucagon Options: 

• • Baqsimi  

• • Gvoke  

• • Zegalogue (two formulations)  

• Included Insulin Pumps: 

• • Tandem Mobi  

• • Tandem t:slim X2  

• • iLet Bionic Pancreas  

• • Medtronic MiniMed 780G System  

• • Omnipod 5  

• • Twiist  

• Proposed Revisions to the Guides: 

• • Add an infographic with images outlining high and low glucose (symptoms, treatment, etc.)  

• • Include a section: “Medical Devices I Wear and What They Do”  

• • Add a QR code linking to more information on continuous glucose monitors (CGMs) 

• • Clarify the distinction between CGMs and insulin pumps, as these are often confused  

• • Include images of different glucagon products, similar to the pump visuals  

• Health Equity Discussion 

• • Explore translation of materials into additional languages  

• • Highlight use of tools such as the Google Translate app (e.g., translating documents via photo)  

• • Recommend adding subtitles in multiple languages to educational videos (e.g., Baqsimi video) to improve accessibility  

• Next Steps: Claire and Nicole will work in the discussed revisions and work with the Marketing team to finalize these documents. We will share with the group when complete.  

 

Prior Authorization (PA) Discussion 

Discussion focused on potential annual survey topics and the burden of prior authorizations for people with type 1 diabetes (PWT1D). 

• Key Points: 
  • PAs can act as barriers to insulin and essential supplies  

• • Existing standards of care may be undermined by administrative requirements  

• • PAs are not always thoroughly reviewed  

• • Delays can lead to:  

• • • Increased stress  

• • • Emergency department visits  

• • • Hospitalizations  

• • • Rationing of supplies  
• Data Needs: 
  • Evidence demonstrating the cost impact of delays on payers  
• Suggested Improvements: 
  • Reduce (but not eliminate) the number of PAs  

• • Extend PA approval time periods  

• • Establish a fast-track process for diabetes-related needs  

 

2026–2028 Co-Chair Term 

• The committee expressed gratitude to Emily Coppedge, CPNP, CDCES, and Jeniece Ilkowitz, BSN, RN, MA, CDCES, for their leadership and contributions. 

 

Incoming Chair Announcement: 

• Stephanie Ogburn, BSN, RN, CDCES, LSSGB (Cook Children’s Medical Center) 

• Term: June 1, 2026 – May 31, 2028 

 

Next PwD Advisory Meeting: Wednesday July 15th 2-3pm EST